Search research articles
Contact Us
Filters
Showing results (1-10 of 122) with videos related to
Page
of 13
Sort By:
Hematology. American Society of Hematology. Education Program
|
December 7, 2019
Evidence-Based Minireview: Does achieving MRD negativity after initial therapy improve prognosis for high-risk myeloma patients?
Surbhi Sidana, Elisabet Manasanch
Journal of the National Comprehensive Cancer Network : JNCCN
|
December 11, 2023
Integrating Immune Therapies for the Treatment of Multiple Myeloma
Lekha Mikkilineni, Surbhi Sidana
Blood Advances
|
November 13, 2019
CAR T-cell therapy: is it prime time in myeloma?
Surbhi Sidana, Nina Shah
Hematology. American Society of Hematology. Education Program
|
December 7, 2019
CAR T-cell therapy: is it prime time in myeloma?
Surbhi Sidana, Nina Shah
Current Hematologic Malignancy Reports
|
March 17, 2021
Antibody-Based Treatment Approaches in Multiple Myeloma
Hitomi Hosoya, Surbhi Sidana
Blood and Lymphatic Cancer : Targets and Therapy
|
August 25, 2022
Differential Diagnosis of Waldenström's Macroglobulinemia and Early Management: Perspectives from Clinical Practice
Shashank Cingam, Surbhi Sidana
Hematology. American Society of Hematology. Education Program
|
December 9, 2023
Managing side effects: guidance for use of immunotherapies in multiple myeloma
Emily C Liang, Surbhi Sidana
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting
|
June 8, 2023
Embracing Myeloma Chimeric Antigen Receptor-T: From Scientific Design to Clinical Impact
Hitomi Hosoya, Paula Rodriguez-Otero, Surbhi Sidana, et al.
Plos One
|
August 16, 2014
Symptomatic and incidental venous thromboembolic disease are both associated with mortality in patients with prostate cancer
Shruti Chaturvedi, Surbhi Sidana, Paul Elson, et al.
The Australasian Medical Journal
|
August 1, 2012
Prevalence of depression in students of a medical college in New Delhi: A cross-sectional study
Surbhi Sidana, Jugal Kishore, Vidya Ghosh, et al.
Page
of 13
Search research articles
Search
Showing results (1-10 of 122) with videos related to
Sort By:
Page
of 13
Hematology. American Society of Hematology. Education Program
|
December 7, 2019
Evidence-Based Minireview: Does achieving MRD negativity after initial therapy improve prognosis for high-risk myeloma patients?
Surbhi Sidana, Elisabet Manasanch
Journal of the National Comprehensive Cancer Network : JNCCN
|
December 11, 2023
Integrating Immune Therapies for the Treatment of Multiple Myeloma
Lekha Mikkilineni, Surbhi Sidana
Blood Advances
|
November 13, 2019
CAR T-cell therapy: is it prime time in myeloma?
Surbhi Sidana, Nina Shah
Hematology. American Society of Hematology. Education Program
|
December 7, 2019
CAR T-cell therapy: is it prime time in myeloma?
Surbhi Sidana, Nina Shah
Current Hematologic Malignancy Reports
|
March 17, 2021
Antibody-Based Treatment Approaches in Multiple Myeloma
Hitomi Hosoya, Surbhi Sidana
Blood and Lymphatic Cancer : Targets and Therapy
|
August 25, 2022
Differential Diagnosis of Waldenström's Macroglobulinemia and Early Management: Perspectives from Clinical Practice
Shashank Cingam, Surbhi Sidana
Hematology. American Society of Hematology. Education Program
|
December 9, 2023
Managing side effects: guidance for use of immunotherapies in multiple myeloma
Emily C Liang, Surbhi Sidana
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting
|
June 8, 2023
Embracing Myeloma Chimeric Antigen Receptor-T: From Scientific Design to Clinical Impact
Hitomi Hosoya, Paula Rodriguez-Otero, Surbhi Sidana, et al.
Plos One
|
August 16, 2014
Symptomatic and incidental venous thromboembolic disease are both associated with mortality in patients with prostate cancer
Shruti Chaturvedi, Surbhi Sidana, Paul Elson, et al.
The Australasian Medical Journal
|
August 1, 2012
Prevalence of depression in students of a medical college in New Delhi: A cross-sectional study
Surbhi Sidana, Jugal Kishore, Vidya Ghosh, et al.
Page
of 13